Notice of Change to Correct Eligibility Information under RFA-RM-22-008; "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)"
Notice Number:
NOT-RM-22-011

Key Dates

Release Date:

March 18, 2022

Related Announcements

RFA-RM-22-008 - NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

The purpose of this Notice of Change is to update Eligibility Information under Eligible Organizations under RFA-RM-22-008; "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional)".

Below is the updated information regarding eligibility for this announcement:

This opportunity is NOT available to Federal Government.

Eligible Organizations

Higher Education Institutions

  • Public/State Controlled Institutions of Higher Education
  • Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

  • Hispanic-serving Institutions
  • Historically Black Colleges and Universities (HBCUs)
  • Tribally Controlled Colleges and Universities (TCCUs)
  • Alaska Native and Native Hawaiian Serving Institutions
  • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

Nonprofits Other Than Institutions of Higher Education

  • Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
  • Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

Foreign Institutions

Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Inquiries

Please direct all inquiries to:

Jessica M. Calzola, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7474
Email: FIRSTNIH@nih.gov